Clinical Trial Update: Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial of OROS Methylphenidate Hydrochloride in adults with ADHD has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• OROS Methylphenidate Hydrochloride (OROS MPH) (methylphenidate hydrochloride)

Snippet

Sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 4 | Status: COMPLETED | Results posted: 2011-08-05